首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1800350篇
  免费   177635篇
  国内免费   1836篇
  1979821篇
  2021年   18559篇
  2019年   16419篇
  2018年   20011篇
  2017年   18809篇
  2016年   29966篇
  2015年   43840篇
  2014年   52049篇
  2013年   78323篇
  2012年   52903篇
  2011年   45444篇
  2010年   49276篇
  2009年   48900篇
  2008年   41168篇
  2007年   40351篇
  2006年   42464篇
  2005年   43384篇
  2004年   42343篇
  2003年   39603篇
  2002年   37292篇
  2001年   60607篇
  2000年   58717篇
  1999年   51608篇
  1998年   28806篇
  1997年   28689篇
  1996年   27689篇
  1995年   25872篇
  1994年   25393篇
  1993年   24886篇
  1992年   43844篇
  1991年   42061篇
  1990年   40517篇
  1989年   40636篇
  1988年   37559篇
  1987年   35550篇
  1986年   33540篇
  1985年   34896篇
  1984年   31848篇
  1983年   27671篇
  1982年   25256篇
  1981年   23730篇
  1980年   22250篇
  1979年   27984篇
  1978年   24348篇
  1977年   22873篇
  1976年   21465篇
  1975年   21956篇
  1974年   23061篇
  1973年   23215篇
  1972年   20175篇
  1971年   18444篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
We have identified mouse and human FKBP60, a new member of the FKBP gene family. FKBP60 shares strongest homology with FKBP65 and SMAP. FKBP60 contains a hydrophobic signal peptide at the N-terminus, 4 peptidyl-prolyl cis/trans isomerase (PPIase) domains and an endoplasmic reticulum retention motif (HDEL) at the C-terminus. Immunodetection of HA-tagged FKBP60 in NIH-3T3 cells suggests that FKBP60 is segregated to the endoplasmic reticulum. Northern blot analysis shows that FKBP60 is predominantly expressed in heart, skeletal muscle, lung, liver and kidney. With N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as a substrate, recombinant GST-FKBP60 is shown to accelerate effectively the isomerization of the peptidyl-prolyl bond. This isomerization activity is inhibited by FK506. mFKBP60 binds Ca2+ in vitro, presumably by its C-terminal EF-hand Ca2+ binding motif, and is phosphorylated in vivo. hFKBP60 has been mapped to 7p12 and/or 7p14 by fluorescence in situ hybridization (FISH).  相似文献   
3.
4.
Squilla mantis hemocyanin is composed of two hexameric subunits but has electron microscopic profiles different from other bis-hexameric hemocyanins, e.g. Astacus and Homarus. We distinguished three different electron microscopic profiles of S. mantis hemocyanin: two sideviews and a topview. These profiles were studied using computer image alignment and correspondence analysis [Van Heel, M. and Frank, J. (1981) Ultramicroscopy 6, 187 - 194]. With the results of this analysis we were able to build a three-dimensional model for the quaternary structure of this hemocyanin. In this model the two hexamers are stacked in such a way that their hexagonal surfaces overlap to about 60% of their width. In the overlap area four subunits are arranged in two different interhexameric pairs, each forming a bridging area between the two hexamers.  相似文献   
5.
6.
7.
A patient with chronic anemia is presented who radiologically showed prominent rugae of the stomach. Angiography demonstrated an arteriovenous malformation with a large feeding artery and prominent draining veins.  相似文献   
8.
9.
10.
Conventional therapies for prostate cancer, especially in its androgen-independent form, may result in the survival of small populations of resistant cells with tumor-initiating potential. These “cancer stem cells” are believed to be responsible for cancer relapse, and therapeutic strategies targeting these cells are of great importance. Telomerase is a ribonucleoprotein enzyme responsible for telomere elongation and is activated in the majority of malignancies, including prostate cancer, but is absent in most normal cells. Putative tumor-initiating cells have significant levels of telomerase, indicating that they are an excellent target for telomerase inhibition therapy. In this review, we present some evidence for the hypothesis that conventional therapies (standard chemotherapy and/or radiation therapy) in combination with telomerase inhibitors may result in effective and more durable responses.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号